This Vaccine Could Turn the Tides Against Deadly Pancreatic
Cancer
"In a new study published Wednesday in Nature, U.S. researchers unveiled
a new personalized mRNA vaccine that can be used to combat a particular
form of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC).
In a Phase 1 trial, PDAC patients jabbed with the vaccine in combination
with chemotherapy and immunotherapy developed a substantial immune
response that remained robust even 18 months later."
See:
https://www.thedailybeast.com/new-mr...creatic-cancer